Real-time imaging with confocal laser endomicroscopy (CLE) probes that fit in standard endoscopes has emerged as a
clinically feasible technology for optical biopsy of bladder cancer. Confocal images of normal, inflammatory, and
neoplastic urothelium obtained with intravesical fluorescein can be differentiated by morphologic characteristics. We
compiled a confocal atlas of the urinary tract using these diagnostic criteria to be used in a prospective diagnostic
accuracy study. Patients scheduled to undergo transurethral resection of bladder tumor underwent white light cystoscopy
(WLC), followed by CLE, and histologic confirmation of resected tissue. Areas that appeared normal by WLC were
imaged and biopsied as controls. We imaged and prospectively analyzed 135 areas in 57 patients. We show that CLE
improves the diagnostic accuracy of WLC for diagnosing benign tissue, low and high grade cancer. Interobserver
studies showed a moderate level of agreement by urologists and nonclinical researchers. Despite morphologic
differences between inflammation and cancer, real-time differentiation can still be challenging. Identification of bladder
cancer-specific contrast agents could provide molecular specificity to CLE. By using fluorescently-labeled antibodies or
peptides that bind to proteins expressed in bladder cancer, we have identified putative molecular contrast agents for
targeted imaging with CLE. We describe one candidate agent - anti-CD47 - that was instilled into bladder specimens.
The tumor and normal urothelium were imaged with CLE, with increased fluorescent signal demonstrated in areas of
tumor compared to normal areas. Thus, cancer-specificity can be achieved using molecular contrast agents ex vivo in
conjunction with CLE.
Probe-based confocal laser endomicroscopy (pCLE) is an emerging technology for in vivo optical imaging of the urinary
tract. Particularly for bladder cancer, real time optical biopsy of suspected lesions will likely lead to improved
management of bladder cancer. With pCLE, micron scale resolution is achieved with sterilizable imaging probes (1.4 or
2.6 mm diameter), which are compatible with standard cystoscopes and resectoscopes. Based on our initial experience
to date (n = 66 patients), we have demonstrated the safety profile of intravesical fluorescein administration and
established objective diagnostic criteria to differentiate between normal, benign, and neoplastic urothelium. Confocal
images of normal bladder showed organized layers of umbrella cells, intermediate cells, and lamina propria. Low grade
bladder cancer is characterized by densely packed monomorphic cells with central fibrovascular cores, whereas high
grade cancer consists of highly disorganized microarchitecture and pleomorphic cells with indistinct cell borders.
Currently, we are conducting a diagnostic accuracy study of pCLE for bladder cancer diagnosis. Patients scheduled to
undergo transurethral resection of bladder tumor are recruited. Patients undergo first white light cystocopy (WLC),
followed by pCLE, and finally histologic confirmation of the resected tissues. The diagnostic accuracy is determined
both in real time by the operative surgeon and offline after additional image processing. Using histology as the standard,
the sensitivity, specificity, positive and negative predictive value of WLC and WLC + pCLE are calculated. With
additional validation, pCLE may prove to be a valuable adjunct to WLC for real time diagnosis of bladder cancer.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.